on BioNxt Solutions Inc. (CVE:BNXT)
BioNxt Solutions Inc. Initiates $2.5 Million Private Placement
Vancouver-based BioNxt Solutions Inc. has announced a non-brokered private placement of up to 10 million units, priced at $0.25 per unit, with potential gross proceeds of $2.5 million. Each unit comprises one common share and one share purchase warrant, allowing the holder to acquire an additional share at $0.50 within 24 months post-closing.
The company plans to utilize the raised funds to advance its European-based research and development, including a human clinical study, alongside broader operational needs. Eligible finders may receive cash fees and warrants as part of the offering, subject to conditions and Securities Exchange acceptance.
The offering, subject to CSE's rules, includes a statutory four-month hold period. BioNxt focuses on next-generation drug delivery and has ongoing projects in North America and Europe, targeting key therapeutic sectors.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BioNxt Solutions Inc. news